Skip to main content
. 2022 Nov 17;2022(11):CD013652. doi: 10.1002/14651858.CD013652.pub2

Li 2020 [A].

Study characteristics
Patient Sampling Purpose: Diagnosis of acute‐phase infections
Design: Single‐group study estimating sensitivity alone:
49 NAT‐confirmed 2019‐nCoV infected patients (hospitalised patients)
Recruitment: Not stated
Prospective or retrospective: Not stated
Sample size: 49 (49)
Further detail: no more details available
Patient characteristics and setting Setting: hospitalised patients
Location: The Fifth Medical Centre of PLA General Hospital of China
Country: China
Dates: December 2019 to February 2020
Symptoms and severity: 12 (24%) severe; 37 (76%) mild illness; fever (41/49), cough (26/49), fatigue (11/49), dyspnoea (6/49), diarrhoea symptom (0/49); 17 had other systematic diseases (8 hypertension, 5 diabetes, 2 asthma, 1 AIDS, 1 tuberculosis, 1 hepatitis)
Demographics: 30, 61% male; median age 43y (IQR: 3 to 79y)
Exposure history: 35 patients had been to Wuhan before illness onset or lived in Wuhan city, others had never been to Wuhan recently.
Non‐Covid group 1: NA
Index tests Test name: [A] SP‐based IgG/IgM ELISA; [B] N‐protein based IgG/IgM ELISA
Manufacturer: [A] Hotgen Biotech (Beijing, China); [B] Livzon Group (Guangdong, China)
Antigen target:
[A] S (Spike);
[B] N (Nucleocapsid) protein.
Evaluation setting: Laboratory
Test method: ELISA
Timing of samples: Day 2 to 45 pso; 40 samples collected at < 10 days; up to 41 samples > 10 days
Samples used: serum
Test operator: not reported
Definition of test positivity: the S/CO values ≥ 1 considered positive results, < 1 negative
Blinding reported: Unclear
Threshold predefined: not reported
Target condition and reference standard(s) Reference standard: NAT; no further details
Samples used: not reported
Timing of reference standard: Not reported
Blinded to index test: yes, reference standard done before index test
Incorporated index test: no
Definition of non‐COVID cases: NA
Samples used:
Timing of reference standard:
Blinded to index test:
Incorporated index test:
Flow and timing Time interval between index and reference tests: not reported
All patients received same reference standard: Yes; all NAT‐tested
Missing data: none reported
Uninterpretable results: none reported
Indeterminate results: none reported
Unit of analysis: 206 serum samples from 49 patients
Comparative  
Notes Funding: This work was supported by the Emergency Project for 2019‐nCoV of PLA General Hospital (20EP013).
Publication status: Pre‐print
Source: Lancet Infectious Diseases
Author COI: authors reported no conflict of interest.
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear    
Was a case‐control design avoided? No    
Did the study avoid inappropriate exclusions? Unclear    
Did the study avoid inappropriate inclusions? Unclear    
Could the selection of patients have introduced bias?   High risk  
Are there concerns that the included patients and setting do not match the review question?     High
DOMAIN 2: Index Test (All tests)
DOMAIN 2: Index Test (Antibody tests)
Were the index test results interpreted without knowledge of the results of the reference standard? Unclear    
If a threshold was used, was it pre‐specified? Yes    
Could the conduct or interpretation of the index test have introduced bias?   Unclear risk  
Are there concerns that the index test, its conduct, or interpretation differ from the review question?     Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Unclear    
Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear    
The reference standard does not incorporate the index test Yes    
Could the reference standard, its conduct, or its interpretation have introduced bias?   Unclear risk  
Are there concerns that the target condition as defined by the reference standard does not match the question?     Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? Unclear    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? Unclear    
Did all participants receive a reference standard? Yes    
Were results presented per patient? Yes    
Could the patient flow have introduced bias?   Unclear risk